UK court allows CMA to amend Pfizer/Flynn appeal
A UK appeal court has granted permission for the Competition and Markets Authority to amend its grounds of appeal in the Pfizer/Flynn excessive pricing case, saying the United Brands test needs to be addressed.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10